Bullous herpes zoster.
Wong KJ, Osowicki J, Seaby E, Curtis N, Gwee A.
J Pediatr. 2014 Mar;164(3):667. doi: 10.1016/j.jpeds.2013.10.026. Epub 2013 Nov 16.
Skin Infections.
Clebak KT, Malone MA.
Prim Care. 2018 Sep;45(3):433-454. doi: 10.1016/j.pop.2018.05.004.
Bullous herpes zoster masquerading as a bullous pemphigoid flare: A case report.
Shehadah A, Yousef A, Hashem A, Mahmoud AA, Aggarwal A.
IDCases. 2023 Jul 7;33:e01846. doi: 10.1016/j.idcr.2023.e01846. eCollection 2023.
Bullous Disseminated Herpes Zoster: An Atypical Presentation.
Jethwa T, Bertasi RAO, Kieneker L, Pattanaik S, Pujalte G.
Cureus. 2020 Jul 20;12(7):e9293. doi: 10.7759/cureus.9293.
Bullous herpes zoster.
Veraldi S, Carrera C, Gianotti R, Caputo R.
Acta Derm Venereol. 2000 Jan-Feb;80(1):55. doi: 10.1080/000155500750012577.
An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine.
Pirrotta P, Tavares-Da-Silva F, Co M, Lecrenier N, Hervé C, Stegmann JU.
Drug Saf. 2021 Dec;44(12):1341-1353. doi: 10.1007/s40264-021-01118-3. Epub 2021 Oct 7.
Bullous Pemphigoid-Like Presentation of Disseminated Herpes Zoster: A Case Report.
Kakitha R, Shanmugam S.
Indian J Dermatol. 2020 May-Jun;65(3):234-235. doi: 10.4103/ijd.IJD_337_18.
Bullous disorders.
Stollery N.
Practitioner. 2014 Mar;258(1769):32-3.
A Comprehensive Review on HIV-Associated Dermatologic Manifestations: From Epidemiology to Clinical Management.
Mohseni Afshar Z, Goodarzi A, Emadi SN, Miladi R, Shakoei S, Janbakhsh A, Aryanian Z, Hatami P.
Int J Microbiol. 2023 Jul 18;2023:6203193. doi: 10.1155/2023/6203193. eCollection 2023.
Cutaneous manifestations of COVID-19 and COVID-19 vaccination.
Nakashima C, Kato M, Otsuka A.
J Dermatol. 2023 Mar;50(3):280-289. doi: 10.1111/1346-8138.16651. Epub 2023 Jan 13.
